Chips

Butterfly Network's chip licensing drove 71% U.S. growth; CEO says it will dwarf the probe business

The chip story is already revenue: third-quarter US growth of 71 percent came primarily from Embedded, Butterfly's chip-licensing line, including the Midjourney co-development. That counterparty has no outside investors and three studios suing it, and insider sale filings landed the same fortnight.

Richard TangRichard Tangfour-minute read
Share
Joseph DeVivo, chief executive of Butterfly Network, head and shoulders portrait
Joseph DeVivo, chief executive of Butterfly Network, told UBS's medtech team that chip licensing revenue should begin to dwarf the handheld-probe business within a couple of years.

Butterfly Network's+1.23% — Butterfly Network, up 1.23 percent today chief executive, Joe DeVivo, told UBS's medtech team this month that revenue from licensing the company's ultrasound semiconductor should "begin to dwarf" the handheld-probe business within a couple of years, citing more than 12 licensing partners and a fourth-generation chip due next quarter 1. The filings from the same fortnight support the direction and set the limit: the chip money is real, and its most visible consumer endpoint belongs to Midjourney, the AI image-generation company, which has no outside investors and three studios suing it 23.

The chip money is real; the fourth-quarter guide holds it flat

Revenue stepped up to $32.6 million in the second quarter and held there in the third 9. Butterfly attributes the 71 percent jump in US revenue primarily to Embedded, its business licensing the Ultrasound-on-Chip to other companies, including the co-development with Midjourney 2. Gross margin, at 73 percent, was the highest in the company's history 2. The quarter still lost $12.8 million 2. Cash stands at $122.3 million 2.

Operating cash has run negative in seven of eight quarters, and cash is down to $122 million

  • Operating cash flow
  • Cash at quarter end
-$50M$0M$50M$100M$150M$200MQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26$122.3M
Data
Operating cash flowCash at quarter end
Q4 '24-$3.12M$88.78M
Q1 '25-$11.68M$155.21M
Q2 '25-$7.17M$148.14M
Q3 '25-$2.89M$144.23M
Q4 '25$9.03M$150.49M
Q1 '26-$13.89M$137.95M
Q2 '26-$16.27M$124.66M
Q3 '26-$2.27M$122.3M
Operating cash flow and cash at quarter end, in millions of US dollars, from Butterfly Network's SEC filings. Q4 2025 was the only quarter in the span with positive operating cash flow.10

Butterfly's own fourth-quarter guide, $31 million to $34 million, holds revenue on that plateau, and the last step of this size, in late 2025, fell back the following quarter 29. We showed how milestone money shaped this quarter when it landed on October 29; what is new since is the quote itself, from UBS's November 10, 2026, healthcare conference, and the filings that followed it 15.

A partner payment lifts one quarter; only shipped product brings the next one.

Butterfly's revenue stepped up to a plateau, and its own Q4 guide holds it flat

A step up to $32.6 million, held flat by the company's own guide

  • Revenue
  • Estimate
$0M$10M$20M$30M$40MQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26 guide$31–34M$32.6M
Data
Revenue
Q4 '24$22.35M
Q1 '25$21.23M
Q2 '25$23.38M
Q3 '25$21.49M
Q4 '25$31.51M
Q1 '26$26.53M
Q2 '26$32.61M
Q3 '26$32.6M
Q4 '26 guide (estimate)$32.5M ($31–34M)
Quarterly total revenue in millions of US dollars, from SEC filings. The final bar is Butterfly's Q4 2026 guidance, drawn at its $31–34 million midpoint.2,9

The consumer end of the chip story is a defendant

The Embedded product a consumer can touch is Midjourney's full-body scanner, built around 40 Butterfly ultrasound chips 4. At launch it will map body composition only, a choice that avoids the approvals diagnostic imaging requires, with availability planned by the end of 2027 4. It begins with about ten scanners in a San Francisco spa 4. None of that has changed since we reported the scanner's specs on October 5; what has moved is the courtroom 3. Midjourney has no outside investors; its founder, David Holz, has said subscribers pay the service's costs plus a margin 3.

Those subscribers' outputs are what Disney, Universal and Warner Bros. are suing over. The studios allege $300 million of revenue last year, no court has ruled on the fair-use defense, and a hearing on Midjourney's bid to throw out the claim that it helped users infringe is set for November 23, 2026 3. Damages or an injunction would land on the same subscription revenue that funds the scanner, so the chain from Butterfly's chip to a consumer now crosses a courtroom.

The insider sales were scheduled in August, not timed to the talk

Director Jonathan Rothberg filed notice on November 13, 2026, to sell $2.23 million of stock 5. Chief financial officer John Doherty sold $350,000 of shares two days earlier 6. Investing.com reported DeVivo's own sale at about $635,000 7. The filings on record ran under trading plans adopted in mid-August, weeks before the UBS talk, so they read as scheduled diversification rather than doubt 56. Three days after Rothberg's notice, Hood River Capital, an investment manager holding 4.97 percent of Butterfly's shares, filed a routine passive-ownership update 8.

Adoption, not the chip, is what DeVivo says limits Butterfly

DeVivo's own account puts the limit in the training of the person holding the probe: he named ultrasound's learning curve as the obstacle to wider adoption 1. About 33 companies are building AI tools inside Butterfly's ecosystem that help less-experienced users position probes and acquire images, the step that turns the chip into a clinician's tool 1. Butterfly's community-care program does the same work on the clinical side, training nurses and collecting payment per patient and per scan, with first revenue due this month 12.

An instructor guides a colleague through scanning a patient in a hospital bed with a Butterfly probe and smartphone
Butterfly trains clinicians to use the probe; its chief executive names ultrasound's learning curve, not the chip, as the limit on wider adoption.Courtesy of Butterfly Network

One Embedded partner product is on the market, unnamed in the release 2. Until partners beyond Midjourney ship from balance sheets that can pay, the dwarf claim rests on that product, one scanner, one spa and one defendant.

Price the stock on chips shipped by partners that can pay, and treat the UBS quote as a promise until then.

Get Chips by email, free

How AI demand is reshaping chipmakers, memory and the fabs behind them. In our daily email, every weekday.

Loading BFLY

Reader comments

0 comments

    Chips

    Western Digital's $1.5 billion revolver allows 3.75 times leverage after a deal it has not named

    The 8-K's covenant lets leverage rise to 3.75 times after an acquisition, the board's only public hint it is preparing to buy something, while the CEO's $6.2 million sale ran on a schedule adopted in February. The market is pricing a peak; the paperwork is pricing a plan.

    Chips

    Arrow named its $1 billion-a-quarter parts arm Capstone as company inventory hits $7.3 billion

    Arrow Electronics turned its interconnect, passive and electromechanical parts into a standalone business, Capstone, four days after a record quarter that used $441 million of operating cash. The profit sits in $7.3 billion of inventory, and the stock now trades below its 200-day average.

    Chips

    SK hynix will spend $1 billion on Korean chip suppliers, failures included

    SK hynix is spending 1.4 trillion won to speed up how quickly Korean suppliers' tools and materials qualify, because contracts already cover more than half of its 2027–28 capacity. The stock is falling on the other memory cycle, the spot-price one.

    Chips

    TSMC fell nearly 5% in the first session to trade the US chip rule; SMIC rose 7%

    The Commerce rule's foundry clause reaches the world's largest contract chipmaker on a record quarter, and no wire has sized what it costs; SMIC's 7% rise on the same day shows which way investors read the shift.

    Chips

    GCT Semiconductor's 5G ramp slips into 2027 with $17.2 million of cash and a $120 million share-sale line

    GCT Semiconductor's 5G ramp is now guided into the first half of 2027, but its $17.2 million of cash covers about two quarters at the September burn rate. The bridge is a $120 million at-the-market facility, larger than the company's $108 million market value, and the company is set up to sell stock before the ramp delivers revenue.

    Chips

    Intel claims 5.9x Nvidia on double-precision finance math on pre-production silicon

    Intel published the per-workload split the day SC26 opened in Chicago, with no price, no ship date and no independent audit, the same week shareholders sued over a 28.6% one-day drop that erased about $140 billion. For investors the card adds nothing to near-term revenue; the 14A clock is what runs.

    Subscribe to TheInference for free